# FDA Inspection 1081616 - Vitalant - February 22, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/vitalant/b769beff-9cc4-44fb-aa8a-5aadf474ce09
Source feed: FDA_Inspections

> FDA Inspection 1081616 for Vitalant on February 22, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081616
- Company Name: Vitalant
- Inspection Date: 2019-02-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1277087 - 2025-07-23](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/9eaaf206-a9ad-49cb-a50d-f2c357c21edb)
- [FDA Inspection 1277087 - 2025-07-23](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/cd93f5b1-b7f2-4a99-87a3-be0edab4f44b)
- [FDA Inspection 1205605 - 2023-05-04](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/008d1d3f-6a6f-49bb-9e42-d4c567ae8242)
- [FDA Inspection 1017789 - 2017-06-16](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/e1e28767-7bdf-4f53-913e-abf8f40429cf)
- [FDA Inspection 936053 - 2015-07-23](https://www.globalkeysolutions.net/records/fda_inspections/vitalant/55f5785b-f122-4910-8d93-83beb630ae35)

Company: https://www.globalkeysolutions.net/companies/vitalant/d18d6603-e972-4b0a-82c0-9162571cfe46

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d